Next Science Ltd
NXS
Company Profile
Business description
Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with efficacy in eradicating both biofilm-based and free-floating bacteria. Its products include Bactisure, XEPERIENCE and BLASTX. The company derives revenue from North America, New Zealand, and Australia.
Contact
264-278 George Street
Level 14, Australia Square
HWL Ebsworth
SydneyNSW2000
AUST: +61 291887772
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,828.70 | 56.70 | 0.65% |
CAC 40 | 7,738.42 | 75.83 | 0.99% |
DAX 40 | 23,790.11 | 116.82 | 0.49% |
Dow JONES (US) | 44,467.62 | 27.32 | -0.06% |
FTSE 100 | 8,774.69 | 10.64 | -0.12% |
HKSE | 24,221.41 | 149.13 | 0.62% |
NASDAQ | 20,364.65 | 161.76 | 0.80% |
Nikkei 225 | 39,762.48 | 223.85 | -0.56% |
NZX 50 Index | 12,784.29 | 49.76 | 0.39% |
S&P 500 | 6,221.04 | 23.03 | 0.37% |
S&P/ASX 200 | 8,597.70 | 56.60 | 0.66% |
SSE Composite Index | 3,454.79 | 2.95 | -0.09% |